Roy Curtiss, III, Ph.D., of the Biodesign Institute at Arizona State University, has been selected as the recipient of the 2014 AZBio Pioneer Award for Lifetime Achievement by the Arizona Bioindustry Association.
“During his career, Roy Curtiss has had a profound impact on microbiology research and been a true pioneer in developing salmonella-based vaccines that are effective against a range of infectious diseases, which are still the leading cause of worldwide death,” said Joan Koerber-Walker, president and CEO of AZBio. “His contributions since being recruited to Arizona a decade ago have continued unabated, and he is now on the cusp of bringing his remarkable discoveries to the marketplace.”
“Roy’s lifelong dedication and achievements in bioscience research, education and innovation are really quite remarkable, and his efforts have inspired countless life science careers,” said Biodesign Institute Executive Director Raymond DuBois, M.D., Ph.D. “His passion and commitment in taking on the challenges of combating infectious diseases and the impact he is having on urgent societal problems make him a stellar example of the translational research spirit of the Biodesign Institute.”
Curtiss was drawn to ASU President Michael Crow’s vision of a New American University and a new state-of-the-art research enterprise, the Biodesign Institute, which opened in 2004. Shortly after arriving at ASU, Curtiss received the largest support of his career, more than $15.4 million from the Grand Challenges in Global Health initiative, funded by the Bill and Melinda Gates Foundation. He has also received generous and continued support from the National Institutes of Health throughout his career.
Curtiss’ primary focus is alleviating worldwide suffering and death from infectious diseases, particularly in the developing world. At Biodesign, he directs the Center for Infectious Diseases and Vaccinology, where he oversees a 130-member research team working on more than a dozen projects. He is also a professor in ASU’s School of Life Sciences and a member of the prestigious National Academy of Sciences.
One of his major projects is development of a next-generation vaccine against bacterial pneumonia. Bacterial pneumonia kills more children around the world each year than any other infectious disease, and the rising costs of vaccines has spurred researchers to develop new solutions. Curtiss and his global team are trying to perfect a safe, yet potent vaccine to fight pneumonia and can be tolerated even by newborn babies — and orally administered as a single-dose, low-cost solution. If successful, the new vaccine against bacterial pneumonia promises to outperform existing injectable vaccine in terms of safety, affordability, ease of distribution and effectiveness.
Preliminary studies have been successful, and the vaccine technology has moved forward to human clinical trials. In addition, his team is also targeting vaccine development for a host of other diseases, and to protect poultry and livestock against a broad range of bacterial marauders.
Before coming to ASU in 2004, Curtiss was the George William and Irene Keochig Freiberg professor of biology at Washington University in St. Louis, where he chaired the Department of Biology for ten years. His body of published work includes more than 250 reviewed articles. He earned a bachelor’s degree from Cornell University and a doctorate from the University of Chicago.
A ceremony honoring Curtiss will take place at the AZBio Awards on September 17, 2014 at the Phoenix Convention Center. The AZBio Awards ceremony celebrates Arizona’s leading educators, innovators and companies. Each year, AZBio honors bioindustry leaders from across the state of Arizona who are illustrative of the depth, breadth and expertise of our bioscience industry.
Past recipients of the AZBio Pioneer Award for Lifetime Achievement include: David S. Alberts, M.D., Director Emeritus at the Arizona Cancer Center, Raymond L. Woosley, M.D., Ph.D., Chairman Emeritus of the Critical Path Institute, and Thomas M. Grogan, M.D., founder of Ventana Medical Systems, Inc.
For registration and more information, go to www.azbioawards.com.
Roy Curtiss III is a member of the National Academy of Sciences fellow of the American Academy of Microbiology; the American Association for the Advancement of Science; the St. Louis Academy of Sciences; and the Arizona Arts, Science and Technology Academy.
AZBio – The Arizona Bioindustry Association – is comprised of member organizations in business, research, government, and other professions involved in the biosciences. AZBio supports the members of the Arizona bioscience community by providing access to the key resources, connections, and information that support their ability to Connect, Collaborate, Innovate and Succeed thus supporting the growth of a thriving economic ecosystem for Arizona’s Bioscience Industry.
About the Biodesign Institute
The Biodesign Institute at ASU addresses today’s critical global challenges in healthcare, sustainability and security by developing solutions inspired from natural systems and translating those solutions into commercially viable products and clinical practices.
For more information visit biodesign.asu.edu
Joan Koerber-Walker, Arizona Bioindustry Association
Photos available upon request.